Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 4,961–4,980 of 17,937 drug recalls

Drug Recall Terminated Historical recordClass II

Naproxen Sodium Tablets, USP 275 mg 100 Tablets Rx Only NDC 68462-178-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA 4147 Goldmine Road Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations
Recall initiated
August 27, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx only NDC 68462-317-32

by Glenmark Pharmaceuticals Inc., USA

Reason
Lack of Assurance of Sterility
Recall initiated
August 27, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide.

View recall →

Drug Recall Completed Historical recordClass I

X RATED HONEY FOR MEN, packaged in 15g packets, 4 packets per box, UPC 6 13682 41232 2

by Phe Inc

Reason
Marketed without an approved NDA/ANDA: Product found to be tainted with Tadalafil.
Recall initiated
August 18, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass III

Hydroquinone, USP, 4% Skin Bleaching Cream, packaged in 1 oz (28.35g) tube, Rx only, Manufactured for: Westminster Pharmaceuticals, LLC Nashville, TN 37217, NDC 69367-174-01 UPC 3 69367 17401 5

by Monarch PCM, LLC

Reason
Subpotency: one product for active ingredient assay and another one for preservative assay
Recall initiated
September 1, 2021
Reported by FDA
September 29, 2021
Distribution
OH, TN

View recall →

Drug Recall Terminated Historical recordClass III

Sodium Sulfacetamide, 10%, Wash, packaged in bottles: a) 6 fl oz (177 mL) NDC 42808-103-06 UPC 3 42808 10306 5; b) 12 fl oz (354.8 mL) NDC 42808-103-12 UPC 3 42808 10312 6, Rx only, Manufactured in the U.S.A. for Exact-Rx, Inc., Melville, NY 11747

by Monarch PCM, LLC

Reason
Subpotency: one product for active ingredient assay and another one for preservative assay
Recall initiated
September 1, 2021
Reported by FDA
September 29, 2021
Distribution
OH, TN

View recall →

Drug Recall Completed Historical recordClass II

Valproic Acid Oral Solution USP, (250 mg/5 mL), 1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054; Manuractured By: Morton Grove Pharmaceuticals, Inc, Morton Grove, IL 60053. NDC: 60432-621-16

by Morton Grove Pharmaceuticals, Inc.

Reason
CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
Recall initiated
September 3, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide USA and China

View recall →

Drug Recall Completed Historical recordClass II

Promethazine With Codeine Oral Solution, (Promethazine Hydrochloride 6.25 mg/5mL & Codeine Phosphate 10 mg/5 mL), 1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054; Manuractured By: Morton Grove Pharmaceuticals, Inc, Morton Grove, IL 60053. NDC: 60432-606-16

by Morton Grove Pharmaceuticals, Inc.

Reason
CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
Recall initiated
September 3, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide USA and China

View recall →

Drug Recall Completed Historical recordClass II

Promethazine Syrup Plain, 6.25 mg/5 mL (Promethazine Hydrochloride Syrup, USP), 1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054; Manuractured By: Morton Grove Pharmaceuticals, Inc, Morton Grove, IL 60053. NDC: 60432-608-16

by Morton Grove Pharmaceuticals, Inc.

Reason
CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
Recall initiated
September 3, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide USA and China

View recall →

Drug Recall Terminated Historical recordClass III

Sirolimus Tablets 1 mg, 30 Tablets (5 blister cards x 6 unit doses), Rx only, Packaged and Distributed by: American Health Packaging Columbus, OH 43217, NDC 68084-915-25

by American Health Packaging

Reason
Failed Impurities/Degradation Specifications
Recall initiated
May 12, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide within the USA

View recall →

Drug Recall Terminated Historical recordClass II

Metoprolol Tartrate Tablets USP 100 mg, 1000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Highstown Road East Windsor, NJ 08520, NDC 65862-064-99

by Aurobindo Pharma USA Inc.

Reason
Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.
Recall initiated
September 9, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass II

Chantix (varenicline) tablets 1 mg, Carton containing 4 blister packs of 14 tablets each,, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Ireland, NDC 0069-0469-03. EXPIRATION DATE: September 2021 June 2023

by Pfizer Inc.

Reason
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit
Recall initiated
August 13, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Chantix (varenicline) tablets 1 mg, 56 Tablets, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Ireland, NDC 0069-0469-56.

by Pfizer Inc.

Reason
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit
Recall initiated
August 13, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Chantix (varenicline) tablets 0.5mg, 56 Tablets, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Ireland, NDC 0069-0468-56.

by Pfizer Inc.

Reason
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit
Recall initiated
August 13, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Chantix (varenicline) tablets 0.5mg/1mg, 56 Tablets, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Ireland, NDC 00069-0471-03. carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42.1 mg tablets.

by Pfizer Inc.

Reason
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit
Recall initiated
August 13, 2021
Reported by FDA
September 29, 2021
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Carbamazepine 200mg Tablets, USP, 200 mg, 100 Count Unit Dose Cartons, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd., Bharuch-392130, India; Manufactured for: Torrent Pharma, Inc., Basking Ridge, NJ 07920; Distributed by: MAJOR PHARMACEUTICALS, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC 0904-6172-61

by The Harvard Drug Group

Reason
Failed Dissolution Specifications
Recall initiated
August 6, 2021
Reported by FDA
September 29, 2021
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Entacapone Tablets, USP, 200 mg, Rx only, 30 Tablets per unit dose cartons, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152. NDC 0904-6822-04

by The Harvard Drug Group

Reason
Failed Dissolution Specifications
Recall initiated
July 29, 2021
Reported by FDA
September 29, 2021
Distribution
CO, FL, MO, OH

View recall →

Drug Recall Terminated Historical recordClass I

AMINOSYN II 15% An Amino Acid Injection, Sulfite-Free, 2000 mL in flexible containers, Rx ONLY, Hospira, Inc., Lake Forest, IL 60045. NDC 0409-7171-17

by ICU Medical Inc

Reason
Presence of Particulate Matter: Particulate matter identified as fibers, hair, and proteinaceous material along with other particles, found in retain smples.
Recall initiated
September 3, 2021
Reported by FDA
September 22, 2021
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Spironolactone Ophthalmic Solution 0.005 mg/mL, 15 mL bottles, Rx only, Greenpark Compounding Pharmacy

by Prescription Labs Inc dba Greenpark

Reason
Lack of Assurance of Sterility
Recall initiated
August 18, 2021
Reported by FDA
September 22, 2021
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

MIC+Methyl B12 injection Methionine Inositol Choline+Methylcobalamin 25 mg/50 mg/50 mg/1 mg/mL, 10 mL vial sterile, Rx only, Promise Pharmacy 31818 US Hwy 19N Palm Harbor FL 34684 1-888-3PROMIS

by Promise Pharmacy, LLC

Reason
Lack of processing controls
Recall initiated
June 30, 2021
Reported by FDA
September 22, 2021
Distribution
AZ, CO, FL, IL, NJ

View recall →

Drug Recall Terminated Historical recordClass II

Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, packaged in a) 30 mL bottle (NDC 61748-480-30), b) 60 mL bottle (NDC 61748-480-60), Rx only, Manufactured by: Hi-Tech Pharmacal Co. Inc., Amityville,NY 11701

by Akorn, Inc.

Reason
Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product.
Recall initiated
August 13, 2021
Reported by FDA
September 22, 2021
Distribution
USA Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.